Paul Boutin has a must-read report on the danger of biowar. He asked geneticist Roger Brent whether a layperson could learn the skills necessary to sequence a disease.
He got his answer by learning to do it himself.
Making DNA turns out to be easy if you have the right hardware. The critical piece of gear is a DNA synthesizer. Brent already has one, a yellowing plastic machine the size of an office printer, called an ABI 394. “So, what kind of authorization do I need to buy this equipment?” I ask.
“I suggest you start by typing “used DNA synthesizer” into Google,” Brent says.
I hit eBay first, where ABI 394s go for about $5,000. Anything I can’t score at an auction is available for a small markup at sites like usedlabequip.com. Two days later I have a total: $29,700—taxes and shipping not included. Nucleosides (the A, C, T, G genetic building blocks) and other chemicals for the synthesizer cost more than the hardware—in the end, a single base pair of DNA runs about a buck to make. Enough raw material to build, say, the smallpox genome would take just over $200,000.
The real cost of villainy is in overhead. Even with the ready availability of equipment, you still need space, staff, and time. Brent guesses he would need a couple million dollars to whip up a batch of smallpox from scratch. No need for state sponsors or stolen top-secret germ samples. “An advanced grad student could do it,” Brent says.
$2 million dollars puts this out of the reach of the typical suburban mad scientist, but not Osama bin Laden. And we can expect this price to drop. Even now this is a very cheap and easily obtained weapon of mass destruction that’s more dangerous than a nuke. No big labs or large infrastructure is required, and no suspicious purchases would set off alarm bells.
Paul Boutin’s article makes it clear that industry insiders think that a bio-attack is inevitable and imminent.
Every hands-on gene hacker I polled during my project estimated they could synthesize smallpox in a month or two. I remember that game from my engineering days, so I mentally scale their estimates using the old software manager’s formula: Double the length, then move up to the next increment of time. That gives us two to four years—assuming no one has already started working.
So, 2008-2010… if we’re lucky. The West needs to get serious about counter-measures to such attacks. Fortunately there is reason to be optimistic.
Tara O’Toole, director of the University of Pittsburgh’s Center for Biosecurity, says after-the-fact vaccines won’t stop a plague; they take months to develop and deploy. She believes the only option is a general-purpose virus detector and destroyer, which has yet to be invented. The cost would be enormous, but don’t think of it as just an antiterror tool. “If we do what we need to for biodefense, we’re going to do an enormous amount of good for routine health care and global disease,” says O’Toole. “We could, as a planet, eliminate large lethal epidemics of infectious disease in our lifetime.”